A Study of Golimumab in Participants With Active Ankylosing Spondylitis

NCT02186873 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Placebo
DRUG: Golimumab

Sponsor

Janssen Research & Development, LLC